丁丙诺啡围术期管理:麻醉科医生的困境与多学科协作
本文以独幕剧形式呈现围术期丁丙诺啡管理的争议:两位专家分别主张继续与停用。作者指出该领域缺乏国家指南、研究不足,强调需识别ERAS路径中需多学科讨论的患者亚群,并呼吁更深入研究以制定循证指南。
要点
- 围术期丁丙诺啡管理缺乏国家指南,各机构实践存在差异。
- ERAS路径中部分患者需多学科讨论制定个体化围术期计划。
- 需更多研究以制定涵盖危险因素和术后/围产期疼痛的循证指南。
核心结论
- 围术期丁丙诺啡管理是研究不足的领域,缺乏国家指南导致实践差异,需多学科协作和更深入研究。
研究设计与样本
- 本文为独幕剧形式的观点文章,基于近期全国会议上两位专家关于围术期丁丙诺啡管理(继续 vs 停用)的辩论。
主要发现
- 两位专家分别捍卫继续与停用丁丙诺啡的机构政策,主持人呼吁遵循机构层面指南以改善患者结局。
- 作者通过独幕剧展示ERAS路径中需多学科讨论、沟通和以患者为中心制定围术期计划的患者亚群的重要性。
临床怎么用
- 在ERAS路径中应识别需要多学科讨论的丁丙诺啡患者亚群,制定协调的个体化围术期计划。
- 机构层面应制定并遵循围术期丁丙诺啡管理指南以减少实践差异。
局限性
- 丁丙诺啡围术期管理仍是研究不足的课题,缺乏国家指南,现有实践存在变异。
- 需更稳健的研究以制定涵盖危险因素和预期术后及围产期疼痛的全面循证指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We have witnessed a worldwide upsurge of streamlined enhanced recovery after surgery (ERAS) pathways advocating for consistency and compliance within their guidelines. At a recent national conference, two experts defended their institutional policies on perioperative management of buprenorphine, one defending its continuation, while the other suggesting its discontinuation. The moderator diplomatically proclaimed the need to have guidance at the institutional level and following it for favorable patient outcomes. Unfortunately, perioperative management of buprenorphine remains an understudied topic with a lack of national guidelines leading to variations at a local level despite its increased use nationally in the current opioid crisis. Although the moderator made a valid statement, we demonstrate via our one-act play the importance of recognizing a subset of the population within an ERAS pathway that necessitates multidisciplinary discussion, communication, and patient-centric care to formulate a perioperative plan coordinating a patient's care. More robust research is needed to minimize variability in current practices and to further develop comprehensive evidence-based guidelines that encompass risk factors and anticipated postsurgical and peripartum pain for patients on buprenorphine.
引用
- Thakrar S, Lee J, Martin CE, et al. Buprenorphine management: a conundrum for the anesthesiologist and beyond - a one-act play. Reg Anesth Pain Med. 2020. PMID: 32371499. doi:10.1136/rapm-2020-101294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。